Fast Growing Stocks With High Insider Ownership

Results

170

12 new

Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.

170 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	CORT	US$110.69	19.1%	57.0%	US$11.9b	US$135.25	220.5	44.8%	n/a	Pharmaceuticals & Biotech
	ALM New	US$13.31	21.6%	222.3%	US$3.8b	US$24.95	107.6	46.0%	n/a	Materials
	NU New	US$14.48	3.1%	18.5%	US$69.2b	US$17.98	5.6	20.2%	n/a	Banks
	KRMN	US$55.12	20.9%	13.4%	US$7.2b	US$102.00	243.8	52.6%	n/a	Capital Goods
	UPST	US$30.20	13.5%	-55.0%	US$3.0b	US$40.60	48.7	66.5%	n/a	Diversified Financials
	APP	US$417.80	4.6%	7.0%	US$141.0b	US$656.20	35.9	21.7%	n/a	Media
	CBRS	US$214.30	26.5%	n/a	US$51.5b	US$292.00	496.7	73.7%	n/a	Semiconductors
	UXIN	US$1.22	-12.2%	-68.1%	US$275.0m	US$4.00	0.5	69.4%	n/a	Retail
	SMCI	US$30.32	18.0%	-35.2%	US$20.5b	US$37.81	15.7	22.4%	n/a	Tech
	EROC	US$10.73	19.4%	n/a	US$3.1b	US$22.63	2.7	56.3%	n/a	Capital Goods
	IREN	US$38.89	32.7%	112.3%	US$14.6b	US$81.73	87.9	40.2%	n/a	Software
	LSF	US$4.14	-1.4%	-42.0%	US$44.9m	US$5.17	0.9	115.9%	n/a	Food, Beverage & Tobacco
	KVHI	US$9.72	11.0%	86.2%	US$181.3m	n/a	1.6	146.1%	n/a	Tech
	FSUN	US$39.80	1.8%	14.1%	US$2.0b	US$45.75	1.1	97.4%	n/a	Banks
	QTI	US$2.74	1.1%	-46.9%	US$37.6m	US$11.60	1.7	104.2%	n/a	Healthcare
	ABEO	US$6.80	9.1%	6.4%	US$388.7m	US$19.71	5.9	32.9%	n/a	Pharmaceuticals & Biotech
	FRMM	US$6.23	17.8%	-82.6%	US$77.1m	US$9.50	8.7	127.7%	n/a	Pharmaceuticals & Biotech
	METC	US$9.24	-5.5%	-57.4%	US$569.0m	US$24.63	1.2	96.8%	0%	Materials
	OSTX	US$1.60	8.1%	-8.6%	US$72.6m	US$8.92	-2.0	53.5%	n/a	Pharmaceuticals & Biotech
	FIGR	US$28.73	11.3%	n/a	US$6.4b	US$50.71	58.9	53.0%	n/a	Diversified Financials
	TEM New	US$46.70	12.4%	-15.9%	US$8.5b	US$62.64	5.9	45.0%	n/a	Pharmaceuticals & Biotech
	PGY	US$21.80	34.7%	-30.5%	US$1.8b	US$28.50	14.8	35.8%	n/a	Software
	ONON	US$38.19	0.7%	-18.4%	US$12.4b	US$52.64	40.8	23.2%	n/a	Consumer Durables
	YSS	US$13.15	-12.5%	n/a	US$2.0b	US$33.44	4.4	103.3%	n/a	Capital Goods

Page 1 of 5